StocksDeepDive
Snapshot · Russell 3000 · generated 2026-10-17 22:05 UTC

SUPN — Supernus Pharmaceuticals, Inc.

EXPENSIVE (MOS -52.2%) · Quality 55/100

Price
37.88
Intrinsic value
24.89
Margin of safety
-52.2%
Implied growth (reverse DCF)
+25.7%
model assumes +17.6%
Value Score
14.1
Quality
55
Psychology
22.7
Discovery
29.5
price/volume attention only
Moat score
27.5
erosion: watch

Value Score: bottom 20% of Russell 3000 · Quality: top 48%

Open the interactive Deep Dive for SUPN →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/SUPN - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is SUPN undervalued?

As of 2026-10-17, SUPN trades at 37.88 against a computed intrinsic value of 24.89 (-52.2% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Supernus Pharmaceuticals, Inc.'s Value Score?

Supernus Pharmaceuticals, Inc.'s Value Score is 14.1 as of 2026-10-17 - it combines value, quality, crowd psychology and market attention into one number.